Literature DB >> 8457645

Effects of glycosaminoglycans on factor XI activation by thrombin.

D Gailani1, G J Broze.   

Abstract

The recent observation that coagulation factor XI is activated by the serine protease thrombin indicates that factor XI may play a role in sustaining the haemostatic process by activating factor IX, after coagulation has been initiated by the factor VIIa/tissue factor catalytic complex. Since negatively charged substances, such as dextran sulphate or sulphatides, have been shown to enhance the activation of factor XI by thrombin, we investigated the effect of glycosaminoglycans on this reaction. A 60-fold enhancement in activation was observed in the presence of heparin and more modest increases were seen with dermatan sulphate and chondroitin sulphates A and C. The increase in activation was greater if Zn2+ was included in the reactions with glycosaminoglycans. The combination of heparin or chondroitin sulphate C and Zn2+ supported factor XI autoactivation in addition to factor XI activation by thrombin; an effect noted previously only with dextran sulphate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457645

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  11 in total

Review 1.  Polyphosphate: a link between platelets, coagulation and inflammation.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

2.  Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.

Authors:  Cristina Puy; Erik I Tucker; Anton Matafonov; Qiufang Cheng; Keith D Zientek; Dave Gailani; András Gruber; Owen J T McCarty
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

3.  Polyphosphate is a cofactor for the activation of factor XI by thrombin.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

4.  Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.

Authors:  Ivan Ivanov; Ruhama Shakhawat; Mao-Fu Sun; S Kent Dickeson; Cristina Puy; Owen J T McCarty; Andras Gruber; Anton Matafonov; David Gailani
Journal:  Thromb Haemost       Date:  2017-01-26       Impact factor: 5.249

Review 5.  Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation.

Authors:  James H Morrissey; Sharon H Choi; Stephanie A Smith
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

6.  In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps.

Authors:  Denis F Noubouossie; Matthew F Whelihan; Yuan-Bin Yu; Erica Sparkenbaugh; Rafal Pawlinski; Dougald M Monroe; Nigel S Key
Journal:  Blood       Date:  2016-12-05       Impact factor: 22.113

7.  The dimeric structure of factor XI and zymogen activation.

Authors:  Yipeng Geng; Ingrid M Verhamme; Stephen B Smith; Mao-Fu Sun; Anton Matafonov; Qiufang Cheng; Stephanie A Smith; James H Morrissey; David Gailani
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

Review 8.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

9.  Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI.

Authors:  Cristina Puy; Erik I Tucker; Ivan S Ivanov; David Gailani; Stephanie A Smith; James H Morrissey; András Gruber; Owen J T McCarty
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

10.  Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.

Authors:  Srabani Kar; Madhusoodanan Mottamal; Rami A Al-Horani
Journal:  ChemistryOpen       Date:  2020-11-10       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.